VIVE — Viveve Medical Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.28m
- $6.43m
Brief: Viveve Medical Reports Qtrly Loss Per Share Of $0.26
Brief: Viveve Medical Announces Issuance Of Novel U.S. Method Patent For Stress Urinary Incontinence
NASDAQ RESUMED AT 09:50 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM
NASDAQ RESUMED AT 09:45 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Viveve Medical: Surges on positive study results
Brief: Viveve Medical Announced Positive Primary Efficacy Data From Its Three-Arm, Five-Month Stress Urinary Incontinence Feasibility Study
Brief: Viveve Medical Inc Posts Quarterly Loss Per Share Of $0.57
Brief: Viveve Medical - Announces Clearance Of Viveve 2.0 System In Thailand
Brief: Viveve Medical Announces FDA Approval To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence
Brief: Viveve Medical Files Prospectus Relates To Potential Offering Of Up To 5 Mln Shares Of Common Stock By Lincoln Park Capital Fund Llc - SEC Filing
Brief: Viveve Medical Files For Offering Of 5.1 Mln Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Viveve Medical Says May Offer And Sell Up To 5.1 Million Shares Of Common Stock By Selling Stockholders
Brief: Viveve Medical Says Reported $1.3 Million Total Revenue For Q1
Brief: Viveve Medical - Resubmits U.S. Investigational Device Exemption To FDA To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence
Brief: Viveve Medical Announces Topline Results From U.S. Trial For Improvement Of Sexual Function In Women